{"id":745627,"date":"2018-12-14T06:45:00","date_gmt":"2018-12-14T06:45:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/"},"modified":"2025-11-07T01:26:51","modified_gmt":"2025-11-07T06:26:51","slug":"merck-to-acquire-privately-held-antelliq-group","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/","title":{"rendered":"Merck to Acquire Privately Held Antelliq Group"},"content":{"rendered":"<p class=\"bwalignc\">       Establishes Merck Animal Health as a Leader in Emerging Digital        Tracking, Traceability and Monitoring Technology     <\/p>\n<p class=\"bwalignc\">       Complements Merck Animal Health Portfolio of Vaccines and        Pharmaceuticals     <\/p>\n<p>KENILWORTH, N.J.&#8211;(<a target=\"_blank\" href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;Merck [NYSE:MRK], known as MSD outside the United States and Canada, and<br \/>\n      privately held Antelliq Group today announced that the companies have<br \/>\n      signed a definitive agreement under which Merck will acquire Antelliq<br \/>\n      from funds advised by BC Partners. Antelliq will be a wholly owned and<br \/>\n      separately operated subsidiary within the Merck Animal Health Division.<br \/>\n      Merck will make a cash payment of approximately 2.1 billion euros to<br \/>\n      acquire all outstanding shares of Antelliq and will assume Antelliq\u2019s<br \/>\n      debt of 1.15 billion euros, which it intends to repay shortly after the<br \/>\n      closing of the acquisition.\n    <\/p>\n<p>\n      Antelliq is a leader in digital animal identification, traceability and<br \/>\n      monitoring solutions, the fastest growing part of the animal health<br \/>\n      industry, with 360 million euros in sales in the 12-month period ending<br \/>\n      Sept. 30, 2018. These solutions help veterinarians, farmers and pet<br \/>\n      owners gather critical data to improve management, health and well-being<br \/>\n      of livestock and pets. The increasing use of digital technology in<br \/>\n      animal agriculture is driven by the growing demand for protein, food<br \/>\n      traceability and food safety. Identification and monitoring technologies<br \/>\n      will help optimize disease prediction and treatment and this acquisition<br \/>\n      will provide Merck Animal Health with a large, established customer base<br \/>\n      in both areas.\n    <\/p>\n<p>\n      \u201cMerck Animal Health is a leader in the animal health business and has<br \/>\n      delivered consistent above-market growth driven by a broad portfolio of<br \/>\n      innovative pharmaceuticals, vaccines and other value-added technologies<br \/>\n      and services. Antelliq\u2019s people and products complement this portfolio<br \/>\n      by adding market-leading digital products, extending the range of<br \/>\n      solutions we can provide our customers and further driving the growth of<br \/>\n      our business,\u201d said Kenneth C. Frazier, chairman and chief executive<br \/>\n      officer, Merck. \u201cThis acquisition is well aligned with our strategy to<br \/>\n      generate long-term growth and sustainable value for our customers and<br \/>\n      shareholders.\u201d\n    <\/p>\n<p>\n      \u201cMerck has a strong and growing animal health business, and we are<br \/>\n      delighted that our superior offering of technology, products and<br \/>\n      services, as well as our global relationships, together with Merck, will<br \/>\n      bring additional value to our customers,\u201d said Stefan Weiskopf, DVM,<br \/>\n      chief executive officer, Antelliq. \u201cWith more than 60 years of<br \/>\n      experience, we are constantly re-imagining animal care to improve the<br \/>\n      quality of life for animals and for the people who care for them.\u201d\n    <\/p>\n<p>\n      With its extensive suite of digitally connected identification and<br \/>\n      monitoring products, Antelliq is uniquely positioned to support the<br \/>\n      needs of farmers and veterinarians. These products allow access to<br \/>\n      real-time, actionable information to help improve livestock management<br \/>\n      and health outcomes.&nbsp;In addition, Antelliq offers pet owners digitally<br \/>\n      connected products to help them enhance their pets\u2019 quality of life.\n    <\/p>\n<p>\n      \u201cThe animal health industry is rapidly evolving with revolutionary<br \/>\n      digital solutions to manage the health and well-being of livestock and<br \/>\n      companion animals,\u201d said Rick DeLuca, president, Merck Animal Health.<br \/>\n      \u201cAnimal identification, animal monitoring and smart data management are<br \/>\n      critical components of this transformative technology. This acquisition<br \/>\n      represents yet another way that we will ensure our place as a leader in<br \/>\n      animal health, with a substantial and sustainable position, including<br \/>\n      the most innovative, technological solutions to serve our customers.<br \/>\n      Through our commitment to the <i>Science of Healthier Animals\u2122<\/i>, we<br \/>\n      are dedicated to preserving and improving the health, well-being and<br \/>\n      performance of animals.\u201d\n    <\/p>\n<p>\n      Jean-Baptiste Wautier, chairman of Antelliq and partner at BC Partners<br \/>\n      commented, \u201cAntelliq is a unique business which played a pivotal role in<br \/>\n      driving forward the convergence of the animal intelligence and animal<br \/>\n      health industries globally. We are proud of the transformation of the<br \/>\n      company that we initiated together with a fantastic leadership team over<br \/>\n      the past five years and believe that Merck is an ideal partner for<br \/>\n      Antelliq to support the next stage of its growth. As a truly innovative<br \/>\n      market leader with a clear vision and dynamic team, Antelliq has<br \/>\n      significant potential to continue leading the industry, as the use of<br \/>\n      intelligence, data and technology play an increasingly important role in<br \/>\n      animal health and care.\u201d\n    <\/p>\n<p>\n      The closing of the transaction is subject to clearance by antitrust and<br \/>\n      competition law authorities and other customary closing conditions, and<br \/>\n      is expected to close in the second quarter of 2019. Merck was<br \/>\n      represented by Barclays and Centerview Partners and Antelliq was<br \/>\n      represented by Goldman Sachs International and Rothschild &amp; Co.\n    <\/p>\n<p>\n      <b>About Merck<\/b>\n    <\/p>\n<p>\n      For more than a century, Merck, a leading global biopharmaceutical<br \/>\n      company known as MSD outside of the United States and Canada, has been<br \/>\n      inventing for life, bringing forward medicines and vaccines for many of<br \/>\n      the world\u2019s most challenging diseases. Through our prescription<br \/>\n      medicines, vaccines, biologic therapies and animal health products, we<br \/>\n      work with customers and operate in more than 140 countries to deliver<br \/>\n      innovative health solutions. We also demonstrate our commitment to<br \/>\n      increasing access to health care through far-reaching policies, programs<br \/>\n      and partnerships. Today, Merck continues to be at the forefront of<br \/>\n      research to advance the prevention and treatment of diseases that<br \/>\n      threaten people and communities around the world &#8211; including cancer,<br \/>\n      cardio-metabolic diseases, emerging animal diseases, Alzheimer\u2019s disease<br \/>\n      and infectious diseases including HIV and Ebola. For more information,<br \/>\n      visit&nbsp;<a href=\"http:\/\/vip2-msd.com\/merckcom-migrated\/index.html\" rel=\"nofollow\">vip2-msd.com\/merckcom-migrated<\/a><br \/>\n      and&nbsp;connect with us on&nbsp;<a href=\"https:\/\/twitter.com\/Merck\" rel=\"nofollow\">Twitter<\/a>,&nbsp;<a href=\"https:\/\/www.facebook.com\/MerckInvents\/\" rel=\"nofollow\">Facebook<\/a>,&nbsp;<a href=\"https:\/\/www.instagram.com\/merck\/\" rel=\"nofollow\">Instagram<\/a>,<br \/>\n      <a href=\"http:\/\/www.youtube.com\/Merck\" rel=\"nofollow\">YouTube<\/a><br \/>\n      and&nbsp;<a href=\"https:\/\/www.linkedin.com\/company\/merck\" rel=\"nofollow\">LinkedIn<\/a>.\n    <\/p>\n<p>\n      <b>About Antelliq<\/b>\n    <\/p>\n<p>\n      Antelliq is the world\u2019s leading animal intelligence group, providing<br \/>\n      world-class devices for animal identification, monitoring, and<br \/>\n      traceability. Our pioneering monitoring solutions deliver smart data<br \/>\n      products and services for the management and wellbeing of livestock,<br \/>\n      fish and pets. For over 60 years we have been satisfying customer needs<br \/>\n      in over 100 countries, supported by 22 production sites, spanning five<br \/>\n      continents. Antelliq has four regional innovation centers and many<br \/>\n      brands working collaboratively to address some of the world\u2019s most<br \/>\n      pressing challenges: supporting farmers with real-time actionable<br \/>\n      information, providing a deeper connection with pets, and supporting<br \/>\n      conservation. Across Antelliq, our different brands provide the<br \/>\n      technology and intelligence that will be at the heart of overcoming<br \/>\n      these challenges. The name Antelliq is the embodiment of everything we<br \/>\n      stand for: intelligence connecting animals and people. For more<br \/>\n      information, visit <a href=\"https:\/\/www.antelliq.com\/\" rel=\"nofollow\">www.antelliq.com<\/a><br \/>\n<span class=\"bwuline\">.<\/span>\n    <\/p>\n<p>\n      <b>Forward-Looking Statement of Merck &amp; Co., Inc., Kenilworth, N.J., USA<\/b>\n    <\/p>\n<p>\n      This news release of Merck &amp; Co., Inc., Kenilworth, N.J., USA (the<br \/>\n      \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of<br \/>\n      the safe harbor provisions of the U.S. Private Securities Litigation<br \/>\n      Reform Act of 1995. These statements are based upon the current beliefs<br \/>\n      and expectations of the company\u2019s management and are subject to<br \/>\n      significant risks and uncertainties. There can be no guarantees with<br \/>\n      respect to pipeline products that the products will receive the<br \/>\n      necessary regulatory approvals or that they will prove to be<br \/>\n      commercially successful. If underlying assumptions prove inaccurate or<br \/>\n      risks or uncertainties materialize, actual results may differ materially<br \/>\n      from those set forth in the forward-looking statements.\n    <\/p>\n<p>\n      Risks and uncertainties include but are not limited to, general industry<br \/>\n      conditions and competition; general economic factors, including interest<br \/>\n      rate and currency exchange rate fluctuations; the impact of<br \/>\n      pharmaceutical industry regulation and health care legislation in the<br \/>\n      United States and internationally; global trends toward health care cost<br \/>\n      containment; technological advances, new products and patents attained<br \/>\n      by competitors; challenges inherent in new product development,<br \/>\n      including obtaining regulatory approval; the company\u2019s ability to<br \/>\n      accurately predict future market conditions; manufacturing difficulties<br \/>\n      or delays; financial instability of international economies and<br \/>\n      sovereign risk; dependence on the effectiveness of the company\u2019s patents<br \/>\n      and other protections for innovative products; and the exposure to<br \/>\n      litigation, including patent litigation, and\/or regulatory actions.\n    <\/p>\n<p>\n      The company undertakes no obligation to publicly update any<br \/>\n      forward-looking statement, whether as a result of new information,<br \/>\n      future events or otherwise. Additional factors that could cause results<br \/>\n      to differ materially from those described in the forward-looking<br \/>\n      statements can be found in the company\u2019s 2017 Annual Report on Form 10-K<br \/>\n      and the company\u2019s other filings with the Securities and Exchange<br \/>\n      Commission (SEC) available at the SEC\u2019s Internet site (<a href=\"https:\/\/www.sec.gov\/\" rel=\"nofollow\">www.sec.gov<\/a>).\n    <\/p>\n<p class=\"bwalignc\">\n<p>\n<img decoding=\"async\" alt=\"\" src=\"https:\/\/www.businesswire.com\/images\/spacer.gif\" style=\"width:0;height:0\"><br \/>\n<span class=\"bwct31415\"><br \/>\n<\/span><\/p>\n<p>       Merck Media:<br \/>Noreen Verbrugge<br \/>+ 1-973-937-5450<br \/> <a href=\"mailto:Noreen.Verbrugge@merck.com\">Noreen.Verbrugge@merck.com<\/a>     <\/p>\n<p>       Pam Eisele<br \/>+1-267-305-3558<br \/> <a href=\"mailto:Pamela.Eisele@merck.com\">Pamela.Eisele@merck.com<\/a>     <\/p>\n<p>       Antelliq Media<br \/>Piers Hampson<br \/>+ 44 (0) 1954 266 001<br \/> <a href=\"mailto:p.hampson@surepetcare.com\">p.hampson@surepetcare.com<\/a>     <\/p>\n<p>       Prosek Partners (BC\/Antelliq)<br \/>+44 (0)20 3878 8560<br \/> <a href=\"mailto:Pro-bcpartners@prosek.com\">Pro-bcpartners@prosek.com<\/a>     <\/p>\n<p>       Merck Investors:<br \/>Michael DeCarbo<br \/>+ 1-908-740-1807<br \/> <a href=\"mailto:Michael.decarbo@merck.com\">Michael.decarbo@merck.com<\/a>     <\/p>\n<p>       Teri Loxam<br \/>+ 1-908-740-1986<br \/> <a href=\"mailto:teri.loxam@merck.com\">teri.loxam@merck.com<\/a>     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck [NYSE:MRK], known as MSD outside the United States and Canada, and privately held Antelliq Group today announced that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC Partners. Antelliq will be a wholly owned and separately operated subsidiary within the Merck Animal Health Division. Merck will make a cash payment of approximately 2.1 billion euros to acquire all outstanding shares of Antelliq and will assume Antelliq\u2019s debt of 1.15 billion euros, which it intends to repay shortly after the closing of the acquisition. Antelliq is a leader in digital animal identification, traceability and monitoring solutions, the fastest growing part of the animal health industry, with 360 million euros in sales in the 12-month period ending Sept. 30, 2018. These solutions help veterinarians, farmers and pet owners gather critical data to improve management, health and well-being of livestock and pets. The increasing use of<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[65,53,64,289],"class_list":["post-745627","news_item","type-news_item","status-publish","hentry","tag-animal-health","tag-corporate-news","tag-latest-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck to Acquire Privately Held Antelliq Group - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck to Acquire Privately Held Antelliq Group - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck [NYSE:MRK], known as MSD outside the United States and Canada, and privately held Antelliq Group today announced that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC Partners. Antelliq will be a wholly owned and separately operated subsidiary within the Merck Animal Health Division. Merck will make a cash payment of approximately 2.1 billion euros to acquire all outstanding shares of Antelliq and will assume Antelliq\u2019s debt of 1.15 billion euros, which it intends to repay shortly after the closing of the acquisition. Antelliq is a leader in digital animal identification, traceability and monitoring solutions, the fastest growing part of the animal health industry, with 360 million euros in sales in the 12-month period ending Sept. 30, 2018. These solutions help veterinarians, farmers and pet owners gather critical data to improve management, health and well-being of livestock and pets. The increasing use of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T06:26:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.businesswire.com\/images\/spacer.gif\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/\",\"name\":\"Merck to Acquire Privately Held Antelliq Group - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.businesswire.com\\\/images\\\/spacer.gif\",\"datePublished\":\"2018-12-14T06:45:00+00:00\",\"dateModified\":\"2025-11-07T06:26:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.businesswire.com\\\/images\\\/spacer.gif\",\"contentUrl\":\"https:\\\/\\\/www.businesswire.com\\\/images\\\/spacer.gif\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-acquire-privately-held-antelliq-group\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck to Acquire Privately Held Antelliq Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck to Acquire Privately Held Antelliq Group - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/","og_locale":"en_US","og_type":"article","og_title":"Merck to Acquire Privately Held Antelliq Group - Merck.com","og_description":"Merck [NYSE:MRK], known as MSD outside the United States and Canada, and privately held Antelliq Group today announced that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC Partners. Antelliq will be a wholly owned and separately operated subsidiary within the Merck Animal Health Division. Merck will make a cash payment of approximately 2.1 billion euros to acquire all outstanding shares of Antelliq and will assume Antelliq\u2019s debt of 1.15 billion euros, which it intends to repay shortly after the closing of the acquisition. Antelliq is a leader in digital animal identification, traceability and monitoring solutions, the fastest growing part of the animal health industry, with 360 million euros in sales in the 12-month period ending Sept. 30, 2018. These solutions help veterinarians, farmers and pet owners gather critical data to improve management, health and well-being of livestock and pets. The increasing use of","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/","og_site_name":"Merck.com","article_modified_time":"2025-11-07T06:26:51+00:00","og_image":[{"url":"https:\/\/www.businesswire.com\/images\/spacer.gif","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/","name":"Merck to Acquire Privately Held Antelliq Group - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/#primaryimage"},"thumbnailUrl":"https:\/\/www.businesswire.com\/images\/spacer.gif","datePublished":"2018-12-14T06:45:00+00:00","dateModified":"2025-11-07T06:26:51+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/#primaryimage","url":"https:\/\/www.businesswire.com\/images\/spacer.gif","contentUrl":"https:\/\/www.businesswire.com\/images\/spacer.gif"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-acquire-privately-held-antelliq-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck to Acquire Privately Held Antelliq Group"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"5f4385e1-fc42-448c-bb5c-3c4478721a0a","news_item_aria_label":"","media_files":null,"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-to-Acquire-Privately-Held-Antelliq-Group-2018.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745627\/revisions"}],"predecessor-version":[{"id":3674983,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745627\/revisions\/3674983"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=745627"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=745627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}